I woke up to quite some good news today to hear that we are seeing light at the end of the tunnel in the search for a malaria vaccine….
GlaxoSmithKline’s quest to find a malaria vaccine has survived two mergers, a succession of chief executives and lasted nearly 30 years.
But that effort is now on track to deliver the first vaccine against one of the world’s deadliest diseases.
Scientists working on the product will on [8th October 2013] unveil the results of a trial on 15,000 African children, providing the strongest evidence yet that the shot nearly halves the number of cases of malaria in babies aged five to 17 months, and paving the way for its release. …Read More